The brain is considered the final frontier of medical research. The Azrieli Foundation supports scientists and patients navigating the brain health journey.
The Azrieli Foundation is leading the way in philanthropy in Canada and Israel through innovative programs, grants and initiatives which catalyze change. The foundation was established in 1989 by David J. Azrieli, a Holocaust survivor, who became a successful builder after immigrating to Canada. A strong believer in philanthropy, Mr. Azrieli donated most of his fortune to the foundation that bears his name.
Today the Azrieli Foundation is the largest public foundation in Canada with several priority funding areas including Scientific Research and Healthcare and Neurodevelopment, with a strong focus on neurodiverse conditions such as autism and Fragile X syndrome.
Supporting Entire Continuum of Patient Care – From Bench to Bedside A Continuous Virtuous Cycle of Brain Research and Patient Care
This holistic “bench to bedside and back” approach reflects the Foundation’s philosophy that scientific research and patient care are inextricably linked. “We believe this integrated approach will lead to a virtuous cycle where breakthroughs in labs will more quickly and directly help people, and observations in the clinic will drive further breakthroughs in the labs,” says Dr. Naomi Azrieli, CEO and Chair of the Azrieli Foundation.
“Neurodevelopmental research has huge ripple effects, so an insight from research in one area like autism can open new pathways for treatments of many other disorders and disabilities, such as schizophrenia, stroke, and neurodegenerative disorders associated with aging,” says Dr. Azrieli.
Often referred to as the last frontier of science, brain research is entering a new era of holistic understanding. “Scientists and clinicians are on the verge of major advances in understanding and care,” says Dr. Azrieli. She adds, “There has never been a better time to do brain and mental health research.”
